Monday, March 16, 2026

HMM’s New 3D Printing System Could Slash Ship Maintenance Costs and Lead Times

HMM to debut a 3D printing system for ships, enhancing part production and reducing maintenance costs with stainless steel components.

‘We’ll Never Give Up Our Nukes’ – Nuke Right to Survive at the UN of North Korea

North Korea's Deputy Foreign Minister Kim Sun-kyung reaffirmed the regime's non-negotiable nuclear stance at the UN, criticizing U.S. military drills.

The Day Manila Fell: How Japan’s 1942 Occupation Shaped the Pacific War

The Japanese occupation of Manila in 1942 marked a pivotal moment in the Pacific War, leading to suffering and resistance among Filipinos.

Tag: Biotech

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

South Korea’s Pharmaceutical Future: 500 Million USD Investment from Eli Lilly to Boost K-Bio Innovation

South Korea partners with Eli Lilly to boost biotech and pharma industries, investing $500M to enhance innovation and healthcare access.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.